Global Electronic Clinical Outcome Assessment Solutions (eCOA) Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Electronic Clinical Outcome Assessment Solutions (eCOA) Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Market Overview:

The latest research study on the global Electronic Clinical Outcome Assessment Solutions (eCOA) market finds that the global Electronic Clinical Outcome Assessment Solutions (eCOA) market reached a value of USD 1245.64 million in 2022. It’s expected that the market will achieve USD 2863.25 million by 2028, exhibiting a CAGR of 14.88% during the forecast period.

Influence of COVID-19 Outbreak on Electronic Clinical Outcome Assessment Solutions (eCOA) Industry Development

Missed site visits due to travel restriction or confinement, problematic eCOAs without manned help desks, changes in data-monitoring ability, or other study interruptions during the COVID-19 pandemic may result in significant amounts of missing data. Large amounts of missing data could impede the ability to interpret results from COA measures. Methods to address messiness may be COA specific, or teams may introduce study-wide data handling conventions. Sensitivity analyses should be considered when applying missing data rules. Regardless, all methods should seek to support the most reliable and valid data interpretation.
After the epidemic is over, the people will have higher demand for health management and health care, which will promote the growth of medical consumption. And electronic Clinical Outcome Assessment is a method of capturing data electronically in clinical trials. It can substantially increase the quality of study data while meeting regulatory requirements. Out of these factors, more people will go to the hospital, and the intensity of drug research and development will also be strengthened, which will gain more attention from the public for the eCOA solutions.
The COVID-19 has introduced the potential for unprecedented challenges for the conduct and interpretation of results from both clinical and observational studies. As to the eCOA industry, these challenges could result in delays in the ability to complete studies as planned, as well as pose threats to the internal and external validity of these studies. For example, COVID19 may impact the physical health of some study participants and will almost certainly influence the emotional and psychosocial functioning of all study participants, potentially confounding study results. Travel limitations due to social distancing, quarantine, or shelter-in-place orders may limit patient and study team access to sites and other resources. Study participants may be unable or unwilling to attend in-person visits, electronic clinical outcome assessment (eCOA) data collection could be impacted by slow or lost Internet connections, and researchers may not be available to conduct in-person assessments. Notably, these examples do not comprise an exhaustive listing and other unanticipated obstacles may emerge.

Region Overview:

North America had the highest growth rate of all regions.

Company Overview:

ERT Clinical, IQVIA lnc.,Kayentis, Parexel International Corporation and Medidata Solution, Inc are the five key players in the global Electronic Clinical Outcome Assessment Solutions (eCOA) market. These companies have shown consistent growth in revenue, larger volumes of sales and a prominent presence in terms of share in the global Electronic Clinical Outcome Assessment Solutions (eCOA) market in the past 5 years.

ERT is a global company specializing in clinical services and customizable medical devices to biopharmaceutical and healthcare organizations. They have nearly 50 years of combined clinical, therapeutic and regulatory experience as well as technology and process-related insights.

Kayentis, a global provider of digital data capture technologies for sponsors, sites and patients in clinical trials, focuses on bringing simplicity, efficiency and integrity to the collection of clinical trial data. Active in clinical development since 2003, Kayentis has, within the last ten years, specialized in electronic Clinical Outcome Assessment (eCOA) solutions for phase II/III research in a broad range of therapeutic areas. It is now expanding in the field of hybrid trials. Advances in its digital technologies include new functions and apps that facilitate integration with other clinical databases, provide flexible adaptation to clinical workflows and improve patient experience.

Segmentation Overview:

By type, Web Hosted segment accounted for the largest share of market in 2021.

Application Overview:

By application, the Hospitals segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Electronic Clinical Outcome Assessment Solutions (eCOA) market covered in Chapter 3:

Kayentis
Oracle Corporation
eClinical Solutions
Medidata Solution, Inc
WIRB-Copernicus Group
Parexel International Corporation
IQVIA lnc.
ERT Clinical
Signant Health
Merge Healthcare Incorporated
Anju Software, Inc.

In Chapter 4 and Chapter 14.2, on the basis of types, the Electronic Clinical Outcome Assessment Solutions (eCOA) market from 2018 to 2029 is primarily split into:

Web Hosted
Cloud Based
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Electronic Clinical Outcome Assessment Solutions (eCOA) market from 2018 to 2029 covers:

Hospitals
CROs
Pharma & Biotech Organizations
Medical Device Manufacturers
Academic Institutes

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)